Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole PK in compromised GI function
NCT00686543Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of posaconazole in invasive fungal infection (IFI), sponsored by Merck & Co.. Started Dec 2007; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00686543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00686543.